Approval · Notice of Compliance 75 · 2004
FENTANYL TRANSDERMAL SYSTEM: Notice of Compliance 75
Issued February 12, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 75
- Date
- February 12, 2004
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FENTANYL TRANSDERMAL SYSTEM | 02249391 | Cancelled Post Market |
| FENTANYL TRANSDERMAL SYSTEM | 02249413 | Cancelled Post Market |
| FENTANYL TRANSDERMAL SYSTEM | 02249421 | Cancelled Post Market |
| FENTANYL TRANSDERMAL SYSTEM | 02249448 | Cancelled Post Market |